Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Real-time Estimate Cboe BZX 02:44:00 27/10/26 am AEDT			5-day change	1st Jan Change
52.36 ^USD	-1.91%		+1.92%	+42.48%

19/10	Barrington Raises Price Target on IMAX to $60 From $50, Keeps Outperform Rating	MT
15/10	IMAX Has More to Come After Q3 'Victory' Lap, Wedbush Says	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

212dbb0f59da2e9dfb2.0tBdIjo4JilfxTEPMeGiHe8K3tyukU1KFqL3FDUwKqQ.pqUJdXUAaUoyqmFoQaTJMJw9qrTxpxsaL9POc297YOiWgDIQVG5wXhb3dA~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

19/10	Barrington Raises Price Target on IMAX to $60 From $50, Keeps Outperform Rating	MT
15/10	IMAX Has More to Come After Q3 'Victory' Lap, Wedbush Says	MT
14/10	Wedbush Raises Price Target on IMAX to $60 From $54, Keeps Outperform Rating	MT
08/10	B. Riley Raises Price Target on IMAX to $64 From $61, Keeps Buy Rating	MT
24/09	Morgan Stanley Initiates IMAX at Overweight With $63 Price Target	MT
24/08	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
25/07	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
25/07	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
24/07	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
24/07	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
17/07	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
16/07	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
10/07	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
19/05	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
04/05	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
02/05	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
24/04	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
18/04	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
27/02	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
27/02	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
27/02	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
16/12	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
09/12	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
09/12	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
09/12	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT

More recommendations

Other Entertainment Production

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IMAX CORPORATION					+12.4%
	LIVE NATION ENTERTAINMENT, INC.					+16.83%
	SKYDANCE CORPORATION					+15.94%
	UNIVERSAL MUSIC GROUP N.V.					+34.31%
	ROKU, INC.					+2.36%
	WARNER MUSIC GROUP CORP.					+23.14%
	TKO GROUP HOLDINGS, INC.					+33.99%
	BOLLORÉ SE					+13.98%
	MADISON SQUARE GARDEN SPORTS CORP.					+23.68%
	TOHO CO., LTD.					+8.33%
	Average					+18.50%
	Weighted average by Cap.					+19.13%